PHRI is looking for Clinical Research Organization(s) and Clinical Research Associate(s) to assist with regulatory/competent authority applications and site monitoring (both on-site & virtual) for three large, pivotal device clinical trials.
The trials each involve more than 20 countries from all regions of the world (North America, South America, Africa, Europe, Asia and Australia). All three studies are expected to begin regulatory submissions in Q1/Q2 2022.
Total combined sample size is more than 13,000 participants at 900 sites worldwide.
PHRI will consider quotes and proposals for individual countries, multiple countries, entire regions, or all regions for any or all of the trials.
Deadline and how to contact us
The deadline to submit your quote or proposal is November 5, 2021.
To access the study information and required quote format and process, or if you would like more information about any of the studies, please email: monitoringRFQ@phri.ca